NexgenRx Inc.

NexgenRx Inc.

October 18, 2010 16:09 ET

NexgenRx Agrees to Extend Debentures

TORONTO, ONTARIO--(Marketwire - Oct. 18, 2010) - NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) announces that it has agreed to extend the maturity date of all of its previously issued and currently outstanding secured convertible debentures (aggregate principal amount of $2,500,000, $500,000 having been issued in April 2007 and $2,000,000 having been issued in October 2007) from October 12, 2010 to November 26, 2010. No other terms of the Debentures have been amended. The TSX Venture Exchange has approved the extension of the maturity date of the Debentures.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at

Caution Regarding Forward-Looking Statements – This news release contains certain forward-looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    (416) 695-3393 x 801
    (647) 722-2920 (FAX)